Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oleogel-S10 versus standard care for split-thickness skin graft donor-site healing
2012-000777-23Phase 3Completed
- Sponsor
- Birken AG
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Birch bark extract in wound, sponsored by Birken AG. Started Apr 2012; status: completed.
02
Drugs
Birch bark extract
03
Conditions
wound
Beyond the preview
Go deeper on 2012-000777-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000777-23.